What are the recommended guidelines for initiating opioid therapy for acute severe pain, including appropriate dosing, duration, risk assessment, and safety precautions?

Opioid Prescribing for Acute Severe Pain

For acute severe pain from major trauma, burns, or invasive surgery, prescribe immediate-release opioids at the lowest effective dose (e.g., hydrocodone 5 mg/acetaminophen 325 mg every 4 hours as needed) for no more than 3-7 days, only after maximizing nonopioid therapies, and always with patient education about risks and alternatives. 1

When Opioids Are Appropriate

Opioids have a legitimate role specifically for:

• Severe traumatic injuries (crush injuries, burns)
• Invasive surgeries with expected moderate-to-severe postoperative pain
• Other severe acute pain when NSAIDs and alternatives are contraindicated or ineffective 1

Opioids should NOT be first-line for common conditions like low back pain, neck pain, musculoskeletal injuries (sprains, strains), minor surgeries, dental pain, kidney stones, or headaches—nonopioid therapies are equally effective for these 1.

Dosing Strategy

Initial Prescription

• Use immediate-release formulations only (never extended-release for acute pain)
• Start with lowest effective doses:
  • Hydrocodone 5 mg/acetaminophen 325 mg
  • Morphine <0.1 mg/kg IV
  • Hydromorphone <0.015 mg/kg IV
  • Fentanyl <1 μg/kg IV 1, 2

Prescribing Instructions

• "As needed" dosing only—never scheduled around-the-clock dosing
• Example: "Take one tablet every 4 hours as needed for moderate-to-severe pain" 1
• If around-the-clock use exceeds a few days, implement a taper back to baseline 1

Duration Limits

Three days or less is often sufficient; more than 7 days is rarely needed 3. The 2022 CDC guidelines emphasize prescribing for "no longer than the expected duration of pain severe enough to require opioids" 1. Recent prospective data shows median opioid use duration of 7 days among opioid-naive patients, with most achieving pain resolution within 20 days (though surgical and low back pain took longer at 74 and 69 days respectively) 4.

Risk Assessment Requirements

Before Prescribing

Check prescription drug monitoring program (PDMP) for prior opioid use 5

Identify high-risk factors:

• Patient-specific: Sleep apnea, obesity, renal/hepatic impairment, age >65, history of substance use disorder
• Treatment-related: Concurrent sedating medications (benzodiazepines, gabapentinoids, muscle relaxants), high doses
• Environment: Lack of monitoring capability 6

Mandatory Patient Discussion

Discuss before prescribing:

• Expected benefits (realistic pain reduction, not elimination)
• Common risks (constipation, nausea, sedation)
• Serious risks (respiratory depression, overdose, dependence)
• Available alternatives 1

Multimodal Approach (Non-Negotiable)

Never prescribe opioids as monotherapy 7. Always maximize:

Nonpharmacologic therapies:

• Ice, heat, elevation, rest, immobilization
• Early mobilization when appropriate
• Physical therapy modalities 1

Nonopioid pharmacologic agents:

• NSAIDs (topical or oral)
• Acetaminophen
• Consider regional anesthesia for surgical pain 1, 5

Safety Precautions

Co-prescribe Naloxone

Provide naloxone and education on its use, particularly for high-risk patients 3

Storage and Disposal

• Direct observation of first dose when possible
• Educate on safe storage (locked, away from children)
• Develop specific disposal plan before discharge—most patients report leftover opioids (67% in one cohort) 4

Special Populations

Patients already on chronic opioids: Use nonopioid medications first for superimposed acute pain; if additional opioids required, use only for duration of severe pain, then taper back to baseline dose 1

Patients with opioid use disorder: Continue buprenorphine during acute pain episodes (discontinuation worsens outcomes); coordinate with addiction specialists 8

Critical Pitfalls to Avoid

• Never prescribe codeine or tramadol to patients <12 years, adolescents with obesity/sleep apnea, post-tonsillectomy patients, or breastfeeding patients 7
• Avoid scheduled dosing—this increases total opioid exposure without improving pain control 1
• Don't use extended-release formulations for acute pain 1
• Don't ignore concurrent sedating medications—this dramatically increases respiratory depression risk 6
• Don't prescribe without checking PDMP—you may miss ongoing prescriptions from other providers 5

The evidence strongly supports an "analgesia-first" strategy where opioids are reserved for severe pain unresponsive to multimodal nonopioid approaches, prescribed at minimal effective doses for the shortest necessary duration 1, 3.